Jnba Financial Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Jnba Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $3,529 - $3,831	-5 Reduced 33.33%	10 $7,000
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $2,723 - $3,291	5 Added 50.0%	15 $8,000
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $4,386 - $6,024	-16 Reduced 61.54%	10 $4,000
Q3 2019 Nov 01, 2019	BUY	$273.46 - $318.39 $3,554 - $4,139	13 Added 100.0%	26 $7,000
Q1 2019 May 01, 2019	BUY	$372.08 - $439.57 $3,720 - $4,395	10 Added 333.33%	13 $5,000
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $1,007 - $1,209	3 New	3 $1,000
Q3 2018 Nov 01, 2018	SELL	$351.14 - $408.51 $1,053 - $1,225	-3 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	3	3 $1,000

1,490

85.7M

1.53M

1.44M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Jnba Financial Advisors with notifications on news.